Mo1059 CLOSING THE GAP: A NOVEL PILOT PROGRAM TO IMPROVE H. PYLORI SCREENING AND TREATMENT IN THE U.S. REFUGEE POPULATION
Read More →
Maggio 2024
Risultati per: Trattamento dell'infezione da Helicobacter Pylori
Questo è quello che abbiamo trovato per te
1278 DYNAMIC CHANGES OF HOST IMMUNE RESPONSE DURING THE HELICOBACTER PYLORI INDUCED GASTRIC CANCER DEVELOPMENT
Read More →
Maggio 2024
1277 HELICOBACTER PYLROI PROMOTES COLORECTAL CARCINOGENESIS BY DEREGULATING INTESTINAL IMMUNITY AND INDUCING A MUCUSDEGRADING MICROBIOTA SIGNATURE
Read More →
Maggio 2024
333 H. PYLORI INFECTION INDUCES SOX9 THROUGH CAP-DEPENDENT TRANSLATION MEDIATED BY AURKA-EIF4E AXIS
Read More →
Maggio 2024
1242 COMPARISON OF EMPIRICAL THERAPY VERSUS SUSCEPTIBILITY TESTING-GUIDED THERAPY FOR REFRACTORY HELICOBACTER PYLORI INFECTION: A MULTICENTER, OPEN-LABEL, RANDOMIZED CONTROLLED, NON-INFERIORY TRIAL
Read More →
Maggio 2024
306 OPTIMIZING ADHERENCE TO QUADRUPLE THERAPY FOR H PYLORI ERADICATION AMONGST ETHNIC MINORITIES: A QUALITY IMPROVEMENT INITIATIVE AT A SAFETY-NET MEDICAL CENTER
Read More →
Maggio 2024
1262 MOLECULAR IRREVERSIBLENESS IS REMAINED IN ADJACENT MUCOSA OF GASTRIC CANCER MORE THAN 10 YEARS AFTER HELICOBACTER PYLORI ERADICATION
Read More →
Maggio 2024
1259 DDIT4 PREVENTS HELICOBACTER PYLORI-INDUCED GASTRIC METAPLASIA THROUGH METABOLIC REGULATION OF FERROPTOSIS
Read More →
Maggio 2024
1258 THE ROLE OF WEE1 IN GASTRIC CANCER PROGRESSION AND IMMUNE EVASION: INSIGHTS FROM H. PYLORI INFECTION
Read More →
Maggio 2024
656 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY PHASE III CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF BISMUTH QUADRUPLE THERAPY CONTAINING TEGOPRAZAN COMPARED TO ESOMEPRAZOLE IN ERADICATING HELICOBACTER PYLORI IN CHINA
Read More →
Maggio 2024
Sa1352 ARGENTINEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT: EFFECTIVENESS OF FIRST AND SECOND-LINE EMPIRICAL TREATMENT
Read More →
Maggio 2024
Sa1359 COMPARISON OF FOUR DIAGNOSTIC TESTS FOR HELICOBACTER PYLORI INFECTION
Read More →
Maggio 2024
Sa1358 RISK OF SEVERE PEPTIC ULCER DISEASE ASSOCIATED WITH HELICOBACTER PYLORI INFECTION IN A LARGE, COMMUNITY-BASED U.S. POPULATION
Read More →
Maggio 2024
Sa1357 ONLINE AVAILABILITY OF COMMERCIALLY MARKETED HELICOBACTER PYLORI TESTS
Read More →
Maggio 2024
Sa1356 RISK OF MAP-LIKE REDNESS DEVELOPMENT, MAJOR RISK FACTOR OF GASTRIC CANCER, AFTER ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION
Read More →
Maggio 2024
Sa1355 REDUCTION IN HELICOBACTER PYLORI INFECTION AMONG PATIENTS REFERRED FOR UPPER GASTROINTESTINAL ENDOSCOPY IN SANTIAGO, CHILE, BETWEEN 2010-2020
Read More →
Maggio 2024
